logo

Potentiality of phosphorylation of BRCA1 at Ser 1524 to activate p21 in response to X-ray irradiation

LOW ENERGY ACCELERATOR, RAY TECHNOLOGY AND APPLICATIONS

Potentiality of phosphorylation of BRCA1 at Ser 1524 to activate p21 in response to X-ray irradiation

LI Ning
ZHANG Hong
WANG Yanling
WANG Xiaohu
HAO Jifang
ZHAO Weiping
Nuclear Science and TechniquesVol.19, No.3pp.142-146Published in print 20 Jun 2008
35400

The breast and ovarian cancer susceptibility gene BRCA1 encodes a nuclear phosphoprotein, which functions as a tumor suppressor gene. Many studies suggested that multiple functions of BRCA1 may contribute to its tumor suppressor activity, including roles in cell cycle checkpoints, apoptosis and transcription. It is postulated that phosphorylation of BRCA1 is an important means by which its cellular functions are regulated. In this study, we employed phospho-Ser-specific antibody recognizing Ser-1524 to study BRCA1 phosphorylation under conditions of DNA damage and the effects of phosphorylation on BRCA1 functions. The results showed that 10 Gy X-ray treatment significantly induced phosphorylation of Ser-1524 but not total BRCA1 protein levels. The expression both of p53 and p21 increased after irradiation, but ionizing radiation (IR) -induced activation of p21 was prior to that of p53. The percentages of G0/G1 phase remarkably increased after IR. In addition, no detectable levels of 89 kDa fragment of PARP, a marker of apoptotic cells, were observed. Data implied that IR-induced phosphorylation of BRCA1 at Ser-1524 might activate p21 protein, by which BRCA1 regulated cell cycle , but play no role in apoptosis.

BRCA1PhosphorylationCell cycleApoptosis
References
[1] Couch F J, DeShano M L, Blackwood M A, et al. N Engl J Med, 1997, 336: 1409-1415
[2] Kerr P, Ashworth A. Curr Biol, 2001, 11: R668-676
[3] Venkitaraman A R. Cell, 2002, 108: 171-182
[4] Venkitaraman A R. J Cell Sci, 2001, 114(Pt): 3591-3598
[5] Zhang J, Powell S N. Mol Cancer Res, 2005, 3: 531-539
[6] Zhang H, Somasundaram K, Peng Y, et al. Oncogene, 1998, 16: 1713-1721
[7] Chai YL, Cui J, Shao N, et al. Oncogene, 1999, 18: 263-268
[8] MacLachlan T K, Takimoto R, El-Deiry W S. Mol Cell Biol, 2002, 22: 4280-4292.
[9] Lee J S, Collins K M, Brown A L, et al. Nature, 2000, 404: 201-204.
[10] Gatei M, Scott S P, Filippovitch I, et al. Cancer Res, 2000, 60: 3299-3304.
[11] Gatei M, Zhou B B, Hobson K, et al. J Biol Chem, 2001, 276: 17276-17280.
[12] Fabbro M, Savage K, Hobson K, et al. J Biol Chem, 2004, 279: 31251-31258.
[13] Somasundaram K, Zhang H, Zeng Y X, et al. Nature, 1997, 389: 187-190.
[14] Wang Y, Cortez D, Yazdi P, et al. Genes Dev, 2000, 14: 927-939.
[15] Lou Z, Chini C C, Minter-Dykhouse K, et al. J Biol Chem, 2003, 278: 13599-13602.
[16] Zhou B B, Elledge S J. Nature, 2000, 408: 433-439.
[17] Zhang J, Willers H, Feng Z, et al. Mol Cell Biol, 2004, 24: 708-718.
[18] MacLachlan T K, Somasundaram K, Sgagias M, et al. J Biol Chem, 2000, 275: 2777-2785.
[19] Gatei M, Zhou BB, Hobson K, et al. J Biol Chem, 2001, 276: 17276-17280.
[20] Chen Y, Farmer AA, Chen CF, et al. Cancer Res, 1996, 56: 3168-3172.
[21] Ruffner H, Verma M. Proc Natl Acad Sci USA., 1997, 94: 7138-7143.